Sanuwave Health (SNWV)
OTHER OTC:SNWV
US Market

Sanuwave Health (SNWV) Stock Price & Analysis

29 Followers

SNWV Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.03
Previous Close$0.02
Volume855.44K
Average Volume (3M)324.60K
Market Cap
$20.29M
Enterprise Value$36.27M
Total Cash (Recent Filing)$2.94M
Total Debt (Recent Filing)$18.91M
Price to Earnings (P/E)
Beta0.30
Aug 14, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding1,145,974,342
10 Day Avg. Volume253,827
30 Day Avg. Volume324,599
Standard Deviation0.45
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-0.31
Price to Sales (P/S)2.62
Price to Cash Flow (P/CF)4.20
P/FCF Ratio1.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.62
Enterprise Value/Gross Profit2.53
Enterprise Value/Ebitda1.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

15.71%0.00%<0.01%84.29%
15.71% Insiders
<0.01% Other Institutional Investors
84.29% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

SNWV FAQ

What was Sanuwave Health’s price range in the past 12 months?
Sanuwave Health lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
    What is Sanuwave Health’s market cap?
    Currently, no data Available
    When is Sanuwave Health’s upcoming earnings report date?
    Sanuwave Health’s upcoming earnings report date is Aug 14, 2024 which is in 16 days.
      How were Sanuwave Health’s earnings last quarter?
      Sanuwave Health released its earnings results on May 10, 2024. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
        Is Sanuwave Health overvalued?
        According to Wall Street analysts Sanuwave Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Sanuwave Health pay dividends?
          Sanuwave Health does not currently pay dividends.
          What is Sanuwave Health’s EPS estimate?
          Sanuwave Health’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Sanuwave Health have?
          Sanuwave Health has 1,181,273,000 shares outstanding.
            What happened to Sanuwave Health’s price movement after its last earnings report?
            Sanuwave Health reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Sanuwave Health?
              Currently, no hedge funds are holding shares in SNWV
              ---

              Sanuwave Health Stock Smart Score

              Company Description

              Sanuwave Health

              SANUWAVE Health, Inc. operates as a shockwave technology company using non-invasive, high energy, acoustic shockwaves for regenerative medicine and other applications. It focuses on the development and commercialization of non-invasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The company was founded on September 25, 2009 and is headquartered in Suwanee, GA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Citius Pharmaceuticals
              Cytosorbents
              Acasti Pharma
              T2 Biosystems
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis